Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Chaabna, Karima ^a,b   Mohamoud, Yousra A ^a   Chemaitelly, Hiam ^a   Mumtaz, Ghina R ^a   Abu Raddad, Laith J ^a,b  

^a Infectious Disease Epidemiology Group Weill Cornell Medical College Qatar Cornell University Qatar Foundation Education City ^*  (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Djibouti; Epidemiology; Hepatitis C; Incidence; Middle East and North Africa; Prevalence; Somalia; Sudan; Yemen

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DISEASE TRANSMISSION; FEVER; HEPATITIS C; HUMAN; INFECTION CONTROL; INFORMATION PROCESSING; META ANALYSIS; MIDDLE EAST; NORTH AFRICA; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLISHING; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; AFRICA;

AFRICA, NORTHERN; HEPATITIS C; HUMANS; MIDDLE EAST; PREVALENCE;

EID: 84927914128     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-146     Document Type: Article

References (33)

1. Pol S, Corouge M, Sogni P. Oral antiviral therapies for chronic hepatitis C infection. Ther Adv Infect Dis 2013, 1(3):107-116. 4040722, 25165547.
2. Ciesek S, Manns MP. Hepatitis in 2010: the dawn of a new era in HCV therapy. Nat Rev Gastroenterol Hepatol 2011, 8(2):69-71. 10.1038/nrgastro.2010.219, 21293503.
3. Honegger JR, Zhou Y, Walker CM. Will there be a vaccine to prevent HCV infection?. Semin Liver Dis 2014, 34(1):79-88. 10.1055/s-0034-1371081, 24782261.
4. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57(4):1333-1342. 10.1002/hep.26141, 23172780.
5. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, Dalgard O, Dillion JF, Flisiak R, Forns X, Frankova S, Goldis A, Goulis I, Halota W, Hunyady B, Lagging M, Largen A, Makara M, Manolakopoulos S, Marcellin P, Marinho RT, Pol S, Poynard T, Puoti M, Sagalova O, Sibbel S, Simon K, Wallace C, Young K, Yurdaydin C. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011, 31(Suppl 2):30-60.
6. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011, 17(2):107-115. 10.1111/j.1469-0691.2010.03432.x, 21091831.
7. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008 2009, Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International.
8. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis 2013, 13:288. 10.1186/1471-2334-13-288, 3702438, 23799878.
9. Lavanchy D. Hepatitis C virus infection trends in Italy. Hepat Mon 2012, 12(1):46-47. 10.5812/hepatmon.4403, 3298876, 22451844.
10. Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 2010, 53(1):39-43. 10.1159/000252782, 20068339.
11. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007, 96(7):1127-1134. 10.1038/sj.bjc.6603649, 2360117, 17406349.
12. Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol 2014, 11(1):28-35.
13. The World Bank. Countries. [http://www.worldbank.org/en/country#S].
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009, 62(10):1006-1012. 10.1016/j.jclinepi.2009.06.005, 19631508.
15. World Health Organization African Index Medicus (AIM database). [http://indexmedicus.afro.who.int/cgi-bin/wxis.exe/iah/?IsisScript=iah/iah.xis&lang=I&base=AIM].
16. World Health Organization Index Medicus for the Eastern Mediterranean Region (IMEMR). [http://www.emro.who.int/information-resources/imemr/imemr.html].
17. Abu-Raddad LAFA, Semini I, Riedner G, Wilson D. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. The World Bank Press 2010, Washington DC: Publication WBUW.
18. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, Tawil O, Wilson D. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010, 24(Suppl 2):S5-S23.
19. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, Semini I, Tawil O, Akala FA, Wilson D, Abu-Raddad LJ. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med 2014, 11(6):e1001663. 10.1371/journal.pmed.1001663, 4061009, 24937136.
20. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, Higgins JPT, Green S, Available at http://www.cochrane.org/handbook.
21. Clopper CJPES The use of confidence or fiducial limits illustrated in the case of the binomial. Biogeosciences 1934, 26:404-413. Clopper CJPES.
22. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54(10):1046-1055. 10.1016/S0895-4356(01)00377-8, 11576817.
23. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634. 10.1136/bmj.315.7109.629, 2127453, 9310563.
24. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998, 17(8):857-872. 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E, 9595616.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188. 10.1016/0197-2456(86)90046-2, 3802833.
26. Freeman M, Tukey J. Transformations related to the angular and the square root. The Annals of Mathematical Statistics 1950, 21:607-611.
27. Miller JJ. The inverse of the Freeman-Tuckey double arcine transformation. Am Stat 1978, 32(4):138.
28. Schwarzer G. Meta Package. CRAN 2014, 4:1.
29. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009, 172(1):137-159. 10.1111/j.1467-985X.2008.00552.x, 2667312, 19381330.
30. Cochran W. The combination of estimates from different experiments. Biometrics 1954, 10(1):101-129.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
32. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558. 10.1002/sim.1186, 12111919.
33. Borenstein MH, Higgins LV, Rothstein JPT HR. Meta-regression. Introduction to Meta-analysis 2009, 187-204. UK: John Wiley & Sons L.